AI assistant
Bionano Genomics, Inc. — Director's Dealing 2018
Aug 21, 2018
35041_dirs_2018-08-21_3228ba88-5b79-4138-90bc-9bd439baea6b.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: BioNano Genomics, Inc (BNGO)
CIK: 0001411690
Period of Report: 2018-08-21
Reporting Person: LC Fund VI, L.P. (10% Owner)
Reporting Person: LC Healthcare Fund I, L.P. (10% Owner)
Reporting Person: LC Parallel Fund VI, L.P. (10% Owner)
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Series C Convertible Preferred Stock | $0.00 | Common Stock (8545184) | Indirect | ||
| Series D Convertible Preferred Stock | $0.00 | Common Stock (6443565) | Indirect | ||
| Series D-1 Convertible Preferred Stock | $0.00 | Common Stock (27305708) | Indirect | ||
| Series D Convertible Preferred Stock Warrants (Right to Buy) | $0.41 | 2026-03-04 | Series D Convertible Preferred Stock (11263624) | Indirect |
Footnotes
F1: The convertible preferred stock is convertible at any time at the holder's election and automatically converts upon the consummation of a qualified public offering of the registrant. There is no expiration date for any series of preferred stock.
F2: The shares are held as follows: 8,203,376 shares held by LC Fund VI, L.P. ("LC Fund") and 341,808 shares held by LC Parallel Fund VI, L.P. ("Parallel Fund") LC Fund and Parallel Fund are controlled and managed by Legend Capital, a limited liability Chinese company.
F3: The shares are held as follows: 6,143,224 shares held by LC Fund and 300,341 shares held by Parallel Fund. LC Fund and Parallel Fund are controlled and managed by Legend Capital, a limited liability Chinese company.
F4: The shares are held as follows: 3,924,722 shares held by LC Fund, 241,948 shares held by Parallel Fund and 23,139,038 shares held by LC Healthcare Fund I, L.P. ("Healthcare Fund"). LC Fund, Parallel Fund and Healthcare Fund are controlled and managed by Legend Capital, a limited liability Chinese company ("Legend Capital"). The Reporting Person is ultimately controlled and managed by Legend Capital.
F5: The warrants are held as follows: warrant to purchase 10,738,615 shares held by LC Fund and warrant to purchase 525,009 shares held by Parallel Fund. LC Fund and Parallel Fund are controlled and managed by Legend Capital, a limited liability Chinese company.